Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of chinese patients

Pathology and Oncology Research

Volumn 15, Issue 2, 2009, Pages 153-158

  Zhou, Cheng Jun ^a,b   Zhang, Qing Hui ^b   Zhang, Ting Guo ^b   Sun, Shan Zhen ^a   Li, Hong ^b   Wang, Yan ^b   Liu, Zhi Yan ^b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Breast; CyclinD1; ER; Ki 67; Pre cancerous lesions

Indexed keywords

CYCLIN D1; ESTROGEN RECEPTOR; KI 67 ANTIGEN; CCND1 PROTEIN, HUMAN;

ARTICLE; BREAST TUMOR; CHINESE; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRECANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; BREAST; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; METABOLISM; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CYCLIN D1; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MICROSCOPY, FLUORESCENCE; PRECANCEROUS CONDITIONS; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 68949083452     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-008-9100-6     Document Type: Article

References (19)

1. JD Yager NE Davidson 2006 Estrogen carcinogenesis in breast cancer N Engl J Med 354 270 282 10.1056/NEJMra050776 1:CAS:528:DC%2BD28Xls1KjtQ%3D%3D 16421368 (Pubitemid 43113032)
2. AM Shaaban JP Sloane CR West, et al. 2002 Breast cancer risk in usual ductal hyperplasia is defined by estrogen receptor- and Ki-67 expression Am J Pathol 160 2 597 604 11839580
3. HB Muss JY Bunn A Crocker, et al. 2007 Cyclin D-1, interleukin-6, HER-2/neu, transforming growth factor receptor-II and prediction of relapsein women with early stage, hormone receptor-positive breast cancer treated with tamoxifen Breast J 13 4 337 345 10.1111/j.1524-4741.2007.00440.x 1:CAS:528:DC%2BD2sXos1yktLc%3D 17593037 (Pubitemid 46985559)
4. Devilea TEF (2003) WHO: pathology and genetics, tumor of the breast and female genital organs. IARC, Lyon, pp 63-73
5. S Krishnamurthy N Sneige 2002 Molecular and biologic markers of premalignant lesions of human breast Adv Anat Pathol 3 185 197 10.1097/00125480-200205000-00002
6. BS Shoker C Jarvis DR Sibson, et al. 1999 Estrogen receptor expression in the normal precancerous breast J Pathol 188 237 244 10.1002/(SICI)1096- 9896(199907)188:3<237::AID-PATH343>3.0.CO;2-8 1:CAS:528:DyaK1MXltVKrur4%3D 10419589 (Pubitemid 29317764)
7. JC Allegra ME Lippman L Green, et al. 1979 Estrogen receptor values in patients with benign breast disease Cancer 44 228 231 10.1002/1097-0142(197907) 44:1<228::AID-CNCR2820440137>3.0.CO;2-0 1:STN:280:DyaE1M3htVyqsA%3D%3D 455247 (Pubitemid 9234936)
8. OW Peterson PE Hoyer B Van Deurs 1986 Frequency and distribution of estrogen receptor-positive cells in normal non lactating human breast tissue J Natl Cancer Inst 77 343 349
9. D Ricketts L Turnbull G Tyall, et al. 1991 Oestrogen and progesterone receptors in the normal female breast Cancer Res 51 1817 1822 1:CAS:528:DyaK3MXhslymtL8%3D 2004366
10. SK Mohsin SG Hilsenbeck DC Allred 2000 Estrogen receptor and growth control in premalignant breast disease Mod Pathol 13 28A
11. DD Giri SAC Dundas JF Nottingham JCE Underwood 1989 Oestrogen receptors in benign epithelial lesions and introductal carcinoma of the breast: an immunohistological study Histopathology 15 575 584 10.1111/j.1365-2559.1989. tb01623.x 1:STN:280:DyaK3c7gvFSmsQ%3D%3D 2606454
12. T Baqai S Shousha 2003 Oestrogen receptor negativity as a marker for high-grade ductal carcinoma in situ of the breast Histopathology 42 440 447 10.1046/j.1365-2559.2003.01612.x 1:STN:280:DC%2BD3s7psVynuw%3D%3D 12713620 (Pubitemid 36605586)
13. SA Fuqua C Wiltschke ZX Zhang, et al. 2000 A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions Cancer Res 60 4026 4029 1:CAS:528:DC%2BD3cXlvFOksbo%3D 10945602
14. RB Clarke A Howell CB Potten E Anderson 1997 Dissociation between steroid receptor expression and cell proliferation in the human breast Cancer Res 57 4987 4991 1:CAS:528:DyaK2sXnsV2ktrY%3D 9371488
15. DR Ciocca MA Fanelli 1997 Estrogen receptor and cell proliferation in breast cancer TEM 8 313 321 1:CAS:528:DyaK2sXnslaisrw%3D 18406820
16. IH Russo J Russo 1998 Role of hormones in mammary cancer initiation and progression J Mammary Gland Biol Neoplasia 3 49 64 10.1023/A:1018770218022 1:STN:280:DC%2BD3c3nslOqsw%3D%3D 10819504
17. BS Shoker C Javis RB Clarke, et al. 1999 Estrogen receptor-positive proliferating cells in the normal and precancerous breast Am J Pathol 155 1811 1815 1:CAS:528:DC%2BD3cXit1Kiuw%3D%3D 10595909
18. L Mussawar PAD Michael BS Shoker, et al. 2001 Subgroups of non-atypical hyperplasia of breast defined by proliferation of oestrogen receptor-positive cells J Pathol 193 333 338 10.1002/1096-9896(2000)9999:9999<::AID- PATH801>3.0.CO;2-# (Pubitemid 32229864)
19. M Kontos M Nikolopoulou DT Trafalis, et al. 2005 The effect of an estrone d-lactam steroid ester derivative on breast cancer cells and its predicted binding interactions with the ligand binding domain of estrogen receptor-alpha Oncol Res 16 129 142 16925114